Skip to content
Screener

Roivant Sciences ROIV Switzerland — Total deferred tax benefit

Other geography segments

Bermuda
$0
United States
$0

Similar metrics at other companies

Lesaka Technologies, Inc. logo
LSAKUS — Deferred Income Tax Expense Benefit
-$2.53M
Lesaka Technologies, Inc. logo
LSAKZA — Deferred Income Tax Expense Benefit
-$3.45M-409%
Wave Life Sciences logo
WVESG — Deferred Income Tax Expense Benefit
$0
Novanta logo
NOVTUS — Deferred Income Tax Expense Benefit
-$1.28M+59.4%
Ovintiv logo
OVVCA — Deferred Income Tax Expense Benefit
$100M+3,233%
Ovintiv logo
OVVUS — Deferred Income Tax Expense Benefit
-$39M-162%

Other financials

Income statement

See full
Revenue$1.4M-33.5%
Operating income-$366.0M-28.5%
Net income-$189.8M+15.0%
EPS (diluted)-$0.26+21.2%

Balance sheet

See full
Cash & equivalents$77.1M-18.7%
Total debt$107.2M+7.5%
Total equity$4.2B-2.6%
Total assets$5.3B+5.4%

Cash flow

See full
Operating cash flow-$270.5M-32.4%
CapEx$419.0K-89.6%
Free cash flow-$270.9M-30.0%

Valuation

See full
Market cap$25.37B+219%
Enterprise value$25.4B+219%
P/S3,368×+3,026×

Profitability

See full
Operating margin-9,130.5%-13,995pp
Net margin-6,079.9%-6,193pp
FCF margin-10,901%-22,382pp

Returns & leverage

See full
Return on equity-17.1%-17.7pp
Debt / equity0.0×
Current ratio16.7×-23.8×

Where this comes from

Reported directly by Roivant Sciences in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxExpenseBenefit.

The source filing: Roivant Sciences’s 10-K, filed May 20, 2026.

Filed
May 20, 2026, 7:17 AM EDT
Fiscal year
FY2025
Accession
0001635088-26-000061
Current taxes: / BermudaYears Ended March 31, 2026 / $Years Ended March 31, 2026 / —Years Ended March 31, 2025 / $Years Ended March 31, 2025 / —Years Ended March 31, 2024 / $Years Ended March 31, 2024 / —
Total current tax expense$$133,329$$48,174$$21,503
Deferred taxes:
Bermuda$$$
United States
Switzerland
Other
Total deferred tax benefit$$$
Total income tax expense$$133,329$$48,174$$21,503

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

FAQ

What is Roivant Sciences's switzerland — total deferred tax benefit?
Roivant Sciences (ROIV) reported switzerland — total deferred tax benefit of $0 in Q1 2026.
What does switzerland — total deferred tax benefit mean?
This metric represents the recognition of future tax savings arising from temporary differences between the carrying amount of assets and liabilities for financial reporting and their tax bases within the Swiss segment. It indicates a reduction in future tax liabilities or a recovery of taxes paid in prior periods. This reflects the accounting impact of timing differences on the segment's tax position.

Ask your AI about Roivant Sciences's switzerland — total deferred tax benefit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude